5 days ago · ICER provides independent evaluations on the value of medical tests, treatments and delivery systems

Founded in 2006 and non-profit incorporated in 2013, ICER has become the nation’s non-partisan, independent, go-to-resource for objective evidence about the value of health care in the U.S. ICER’s appraisals of more than 100 drugs for more than 50 medical conditions, in addition to multiple devices and diagnostics, have demonstrated that ...

Find our most recent treatment assessments, or search from our archive of past assessments to find studies relating to treatments that matter to you.

Mar 3, 2025 · In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these interventions to measure their value and suggest fair prices.

The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests.

ICER is driven by a mission to conduct evidence-based reviews of health care interventions, such as drug, devices and diagnostics, that help patients, doctors, and everyone else in the health care system know what works.

Feb 5, 2025 · tion drugs, other treatments, and diagnostic tests. In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these intervent ons to measure their value and suggest fair prices. ICER also regularly reports on the barriers to care for patients and recommends so

BOSTON, December 12, 2024 – The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription drugs in the United States, highlighting the top 10 drugs with substantial net price increases in 2023.

Mar 11, 2025 · ICER's analysis on the comparative clinical effectiveness and value of treatments for post-traumatic stress disorder. Learn more.

BOSTON, February 5, 2025 – The Institute for Clinical and Economic Review (ICER) today posted its revised Evidence Report assessing the comparative clinical effectiveness and value of suzetrigine (Vertex Pharmaceuticals) for the treatment of acute pain.